DOAC Dosing in Obesity: Efficacy, Safety, and Side Effects
Apixaban and rivaroxaban are safe and effective at standard doses for obese patients. Dabigatran increases bleeding risk. No need to increase DOAC doses - evidence shows standard dosing works.
